Showing results (991-1000 of 1,111) with videos related to

Sort By:
Pageof 112
Journal of Perinatal Medicine|January 1, 1996
Antenatal assessment using the FECG obtained via abdominal electrodesJ A Crowe, M S Woolfson, B R Hayes-Gill, et al.
Molecular Psychiatry|April 23, 2008
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related ConditionsB F Grant, R B Goldstein, S P Chou, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.
Physical Review Letters|June 13, 2015
Collective nature of spin excitations in superconducting cuprates probed by resonant inelastic X-ray scatteringM Minola, G Dellea, H Gretarsson, et al.
Genetics and Molecular Research : GMR|May 13, 2015
A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastomaX M Fu, S L Zhao, J C Gui, et al.
Cell Calcium|May 7, 2021
Involvement of TRPV1 and TRPA1 in the modulation of pacemaker potentials in the mouse ileumJulia Y H Liu, Peng Du, Zengbing Lu, et al.
Neurology|December 22, 2010
Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophyT-H Chen, J-G Chang, Y-H Yang, et al.
Carcinogenesis|December 15, 2010
CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2S Wu, X Lu, Z L Zhang, et al.
Oncogene|September 2, 2018
Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancerZachary A Yochum, Jessica Cades, Hailun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type IaD A Martin, L Zheng, R M Siegel, et al.
Pageof 112